Latest Headlines

  1. Labcorp Expands Collaboration With PathAI To Deploy FDA-Cleared Digital Pathology Platform Nationwide 2/23/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx1, an FDA-cleared digital pathology platform, across its national network of anatomic pathology labs and hospital collaborations.

  2. Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity And Higher Cell Recovery 2/19/2026

    Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions today announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing.

  3. DEXIS Advances Digital Dentistry With Enhanced Lab-To-Clinic Workflow Solutions 2/19/2026

    DEXIS™, a global leader in digital diagnostic imaging and intraoral scanning solutions, today announced significant advancements to its lab-to-clinic workflow solutions during a week of key industry events in Chicago—including LMT Lab Day and Chicago Midwinter Meeting—reinforcing its focus on setting the standard for digital collaboration across dentistry.

  4. Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation For OneBreath™ Platform To Aid Pre-Operative Pneumonia Risk Assessment 2/19/2026

    Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its OneBreath™ platform.

  5. Meridian Life Science Expands Ambient-Stable NGS Portfolio With The Launch Of A Lyophilized Enzymatic DNA Fragmentation Kit 2/18/2026

    The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit.

  6. Fast Code Reader For Simple And Reliable Sample Identification 2/18/2026

    Meet the Micronic Rack Reader DR515, a compact, simple and high-performance 2D code scanning solution designed to enhance efficiency and accuracy in modern laboratory environments.

  7. Project Santa Fe Foundation And Virchow Medical Announce First-Of-Its-Kind Partnership To Advance Proactive Analytics In Clinical Laboratory Medicine 2/17/2026

    The Project Santa Fe Foundation (PSFF) and Virchow Medical have formed a partnership to meet the unmet needs of oncology patients by transforming laboratory insights into proactive clinical analytics.

  8. Molecular Instruments Announces Fully Ambient-Temperature HCR™ Pro RNA-ISH On The BOND-III, Setting A New Standard For Clinical Automation 2/17/2026

    Molecular Instruments (MI), inventor of the HCR technology, today announced the availability of fully ambient-temperature HCR Pro RNA-ISH on the BOND-III, introducing a new class of clinical-grade RNA-ISH engineered for consistency, tissue preservation, and scalable automation.

  9. Waters Introduces Next-Generation Microflow LC Columns With MaxPeak Premier Technology, Delivering Higher Sensitivity With Lower Sample And Solvent Usage 2/17/2026

    Waters Corporation (NYSE: WAT) today launched 1 mm I.D. liquid chromatography (LC) columns with Waters' MaxPeak™ Premier Technology for its ACQUITY™, BioResolve™, and GTxResolve™ Column brands.

  10. FDA 510(k) Clearance Establishes Broad Intended Use For Copan's PhenoMATRIX®, Expanding Clinical Microbiology Capabilities 2/17/2026

    Copan Group announced today that PhenoMATRIX®, its automated image assessment software used with WASPLab® full laboratory automation, received FDA 510(k) clearance as a Class II device in the United States.